Life Non Current Assets Total from 2010 to 2024

Stocks . UK . 
Stock . Life Science REIT
LABS Stock   38.80  0.20  0.52%   
Life Science Non Current Assets Total yearly trend continues to be comparatively stable with very little volatility. Non Current Assets Total are likely to outpace its year average in 2024. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
2010-12-31
Previous Quarter
400.4 M
Current Value
420.4 M
Quarterly Volatility
143.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Life Science financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Life Science's main balance sheet or income statement drivers, such as Interest Income of 2.6 M, Interest Expense of 11.6 M or Selling General Administrative of 5.8 M, as well as many indicators such as . Life financial statements analysis is a perfect complement when working with Life Science Valuation or Volatility modules.
  
This module can also supplement various Life Science Technical models . Check out the analysis of Life Science Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
GMGeneral Motors
FFord Motor

Additional Tools for Life Stock Analysis

When running Life Science's price analysis, check to measure Life Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Science is operating at the current time. Most of Life Science's value examination focuses on studying past and present price action to predict the probability of Life Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Science's price. Additionally, you may evaluate how the addition of Life Science to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY